• Bichet, D., Van Putten, V. & Schrier, R. (1982). Potential role of increased sympathetic activity in impaired sodium and water excretion in cirrhosis. New Engl. J. Med., 307, 15521557.
  • Bilski, A., Dorries, S., Fitzgerald, J., Jessup, R., Tucker, H. & Wale, J. (1980). ICI 118551, a potent B2-adrenoceptor antagonist. Br. J. Pharmac., 69, 292P293P.
  • Caesar, J., Shaldon, S., Chiandussi, L., Guevara, L. & Sherlock, S. (1961). The use of indocyanine green in the measurement of hepatic blood flow and as a test of hepatic function. Clin. Sci., 21, 4357.
  • FitzGerald, D., Gumbrielle, T. & Harry, J. (1982). Effects in man of ICI 118551 (a selective β2-adrenoceptor blocking drug) on some cardiovas-cular responses induced by isoprenaline. Br. J. clin. Pharmac., 13, 586P.
  • Grainger, S., Keeling, P. & Thompson, R. (1983). Failure of changes in indocyanine green clearance to predict changes in liver blood flow after propranolol. Clin. Sci., 64, 2P.
  • Harry, J., Young, J. & Stribling, D. (1982). Effects of ICI 118551, a β2-adrenoceptor blocker, on metabolic changes induced by isoprenline, and tachycardia induced by exercise. Br. J. clin. Pharmac., 14, 584P.
  • Hillon, P., Lebrec, D., Munoz, C., Jungers, M., Goldfarb, G. & Benhamou J-P. (1982). Comparison of the effects of a cardioselective and a nonselective β-adrenoceptor blocker on portal hypertension in patients with cirrhosis. Hepatology, 2, 528531.
  • Jenkins, W., Burroughs, A., Dick, A., Watt, R. & Sherlock, S. (1982). Propranolol for the prevention of recurrent variceal bleeding in cirrhotic patients. European association for the study of the liver, 19.
  • Lebrec, D., De Fleury, P., Rueff, B., Nahum, H. & Benhamou, J-P. (1980). Portal hypertension, size of oesophageal varices and risk of gastrointestinal bleeding in alcoholic cirrhosis. Gastroenterology, 79, 11391144.
  • Lebrec, D., Poynard, T., Hillon, P. & Benhamou, J-P. (1981). Propranolol for the prevention of recurrent gastrointestinal bleeding in patients with cirrhosis. A controlled study. New Engl. J. Med., 305, 13711374.
  • Lebrec, D., Hillon, P., Munoz, C., Golfarb, G., Nouel, O. & Benhamou, J-P. (1982). The effect of propranolol on portal hypertension in patients with cirrhosis—a haemodynamic study. Hepatology, 2, 523527.
  • McGibney, D., Singleton, W., Silke, B. & Taylor, S. (1983). Observations on the mechanism underlying the differences in exercise and isoprenaline tachycardia after cardioselective and nonselective β-adrenoceptor antagonists. Br. J. clin. Pharmac., 15, 1519.
  • Myers, J. & Taylor, W. (1951). An estimation of portal venous pressure by occlusive catheterisation of an hepatic venule. J. clin. Invest., 30, 662663.
  • Pugh, R., Murray-Lyon, I., Dawson, J., Pietroni, M. & Williams, R. (1973). Transection of the oesophagus for bleeding oesophageal varices. Br. J. Surg., 60, 646649.
  • Reynolds, T., Redeker, A. & Geller, H. (1957). Wedged hepatic venous pressure. A clinical evaluation. Am. J. Med., 22, 341350.
  • Ring-Larsen, H., Hesse, B., Henriksen, J. & Christensen, N. (1982). Sympathetic nervous activity and renal and systemic haemodynamics in cirrhosis: plasma norepinephrine concentration, hepatic extraction and renal release. Hepatology, 2, 304310.
  • Richardson, P. & Withrington, P. (1981). Liver blood flow. Gastroenterology, 81, 159173, 356–375.
  • Westaby, D., Macdougall, B., Melia, W. & Williams, R. (1983). Comparison of oral metoprolol and injection sclerotherapy for long term management of variceal bleeding in cirrhosis. Gut, 24, A483.
  • Westaby, D., Bihari, D., Gimson, A., Crossley, I. & Williams, R. (1984). Selective and nonselective β-receptor blockade in patients with cirrhosis and portal hypertension. Gut, 25, 121124.